Related Experiment Video
Updated: May 5, 2026

Author Spotlight: High-Sensitivity Tissue Factor Activity Assay for Plasma Diagnosis
Published on: December 29, 2023
Microparticle bearing tissue factor: a link between promyelocytic cells and hypercoagulable state
Damien Gheldof1, François Mullier2, Nicolas Bailly1
1Hematology Laboratory, NARILIS, Namur Thrombosis and Hemostasis Center (NTHC), CHU UCL Mont-Godinne-Dinant, Université Catholique de Louvain, Belgium.
Microvesicles (MVs) from acute promyelocytic leukemia (APL) cells shed procoagulant factors, increasing venous thromboembolism (VTE) risk. These MVs may predict VTE and disseminated intravascular coagulation (DIC) in APL patients.
Area of Science:
- Hematology
- Biochemistry
- Oncology
Background:
- Patients with hematological malignancies face a significantly higher risk of venous thromboembolism (VTE).
- Acute promyelocytic leukemia (APL) is associated with VTE and disseminated intravascular coagulation (DIC).
- Microvesicles (MVs) expressing Tissue Factor (TF) are implicated in thrombosis in APL.
Purpose of the Study:
- To investigate the procoagulant activity (PCA) of MVs shed by untreated APL cells.
- To determine the role of TF and phospholipids (PL) in the PCA of these MVs.
- To assess the potential of MVs as predictors for VTE and DIC in APL.
Main Methods:
- APL cell lines (NB4, HL-60) and their shed MVs were isolated using filtration.
- Procoagulant activity was measured using thrombin generation assays (TGA).
- TF and phospholipid contributions were assessed using anti-TF antibodies and annexin V.
Main Results:
- NB4 cells shed MVs (<0.45 μm) with high PCA, linked to active TF and PL.
- HL-60 cells exhibited weaker PCA and did not shed PCA-associated MVs (<0.65 μm).
- TF was predominantly in an inactive form in HL-60 cells.
Conclusions:
- APL-derived MVs possess significant procoagulant activity.
- MV-associated TF and PL are key drivers of PCA in APL.
- MVs may serve as predictive biomarkers for VTE and DIC in APL, guiding thromboprophylaxis.
Related Concept Videos
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Venous Thrombosis I: Introduction
Intracellular Signaling Affects Focal Adhesions
Some...

